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Introduction: The placenta is a complex organ and is vital for successful 
fetal development. High volume, low resistance blood flow in the placenta 
is thought to be essential for optimal materno-fetal nutrient exchange. 
Intrauterine Growth Restriction and maternal diabetes are often related to 
abnormal placental perfusion1. In maternal diabetes the placenta is often 
large with abnormal vascular development and increased villous volume on 
histology2. Hence, antenatal assessment of placental vascular function will 
assist in assessing fetal well-being. Intravoxel incoherent motion (IVIM) 
has been shown to be a sensitive method of measuring moving blood 
fraction (f) in the placenta3. 
Aim: To study placental blood flow in normal and diabetic pregnancies. 
Methods: Scanning: With ethics committee approval, 4 normal women and 
6 women with Type 1 diabetes were recruited from Queen’s Medical 
Centre Nottingham during the first trimester of pregnancy and gave 
informed consent to participate in the study involving two scans at 24–26 
weeks and 34–36 weeks gestational age (GA). Scanning was performed on 
a 1.5 T Philips Achieva MRI scanner with 5-element SENSE cardiac coil 
or 4-element SENSE torso coil, depending on the woman’s size. Women 
lay on their right side in the decubitus position to avoid vena cava 
compression and all these scans were conducted with a specific absorption 
rate of < 2.0 W kg-1. The IVIM sequence used was respiratory gated, 
standard diffusion pulsed spin echo sequence acquired with 5 transverse 
slices encompassing the placenta in 108 seconds (TR = 3000 ms, 
TE = 95 ms, FOV = 350×350×107 mm3, resolution = 1.46×1.46×7 mm3, 
slice gap = 18 mm, 12 b values = 0, 1, 3, 15, 47, 80, 115, 206, 246, 346, 
468 and 800 s mm-2, repeated 5 times. Analysis: A region of interest was 
drawn around the whole placenta in a central slice for an intermediate b 
value. Each pixel in the ROI was fitted to the IVIM equation in Box 13 for 
f, D, D* and So in Matlab (R2010a). f is interpreted as the moving blood 
volume in the placenta. Data points corrupted by excessive motion 
identified as lying > 2 standard deviations from the fitted line were 
excluded and the data were refitted. The histogram of f in the ROI was 
found, and the mean, mode and fraction of pixels with f > 0.8 in the 
histogram were found.  
Results: So far only 4 controls and 6 diabetics have completed the study 
and have been analysed for visit 1. Figure 2 shows maps of f for a control 
and diabetic subject and Figure 3 shows the related histograms. 
Considering all subjects, the mean value of f in the normal placenta 
(0.37 ± 0.01) was higher than in the diabetic placenta (0.34 ± 0.03), 
although this was not statistically significant. The mode of the distribution 
was higher in the normal placenta (0.32 ± 0.3) than in the diabetic placenta 
(0.26 ± 0.05) (p = 0.04). However the fraction of the voxels with high 
perfusion (f > 0.8) tended to be higher in diabetics (4.1 %) than controls 
(2.5 %) (p = 0.06). (Data shown in Figure 4) 
Discussion: This is the first report of a difference in the distribution of 
placental blood flow in diabetic placentae. In the normal placenta f was 
fairly uniformly distributed, whilst in the diabetic placenta the f distribution 
was generally shifted to lower f but with small areas of higher f. Figure 2 
demonstrates a negative correlation (R2 = 0.108, all subjects grouped) 
between the fraction of pixels with high f and the mode of the histogram, 
suggesting that areas of particularly high flow are associated with a general 
depression in flow across the rest of the placenta. It has been suggested that 
abnormal spiral artery remodeling causes increased intravascular resistance 
leading to high velocity blood flow in the intervillous spaces. This 
abnormal intervillous circulation causes damage to villous architecture 
affecting the materno-fetal nutrient transfer4. This may be related to the 
abnormal fetal development associated with diabetic pregnancies. 
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BOX 1: The signal attenuation due to the pulsed gradient:  
S = So [ (1 − f)exp(−bD) + fexp(−bD*) ]  
where So = equilibrium signal intensity, f = moving blood volume, 
D = diffusion coefficient,  D* = pseudo diffusion coefficient and 
b = diffusion parameter 
